Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-01-19 | 2024-03-22 | 216653 |
| APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-11-27 | 2023-03-16 | 175901 |
| APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-12-09 | 2023-03-16 | 177606 |
| APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-10-27 | 2024-01-05 | 208417 |
| APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-11-06 | 2024-01-05 | 209336 |
| APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-11-24 | 2024-01-05 | 211481 |
| APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-08-22 | 2024-11-01 | 235692 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2019-03-05 | 2019-04-05 | 77875 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-12-08 | 2023-12-15 | 212937 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-08-12 | 2023-08-18 | 201696 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2022-05-27 | 2022-09-30 | 161448 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-10-20 | 2023-11-10 | 207719 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2019-01-09 | 2019-02-13 | 71659 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-05-19 | 2023-07-27 | 192806 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2024-04-26 | 2024-06-28 | 226318 |
| APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2024-07-12 | 2024-09-06 | 232821 |
| APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2023-04-14 | 2023-07-07 | 189653 |
| APO-ELETRIPTAN | 40MG | TABLET TABLET | Resolved | 2020-09-02 | 2021-11-19 | 123558 |
| APO-ELETRIPTAN | 20MG | TABLET | Resolved | 2017-03-10 | 2020-01-07 | 305 |
| APO-ELETRIPTAN | 20MG | TABLET TABLET | Resolved | 2020-11-26 | 2022-06-03 | 128925 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |